IV
119th CONGRESS
2d Session
H. RES. 1167
IN THE HOUSE OF REPRESENTATIVES
April 14, 2026
Mr. Bell (for himself and Mr. Bilirakis) submitted the following resolution; which was referred to the Committee on Energy and Commerce
RESOLUTION
Expressing support for the designation of the month of April 2026 as Parkinson’s Awareness Month
.
Whereas Parkinson’s disease—
affects over 1,000,000 individuals in the United States with nearly 90,000 individuals diagnosed each year;
is the fastest-growing and second most common neurodegenerative disease in the world;
is believed to be caused by a combination of genetic and environmental factors, but the exact cause in most individuals is still unknown; and
is the 13th leading cause of death in the United States, according to the Centers for Disease Control and Prevention;
Whereas, by the year 2045, it is estimated that the number of individuals in the United States with Parkinson’s disease and related conditions will reach 1,700,000, and will cost the United States $112,400,000,000;
Whereas the symptoms of Parkinson’s disease can include dementia and cognitive impairment, tremors, slowness of movement and rigidity, gait and balance difficulties, speech and swallowing difficulties, depression, and a variety of other symptoms;
Whereas there are millions of family caregivers, friends, and loved ones whose lives are greatly affected by Parkinson’s disease, and recent analysis shows care partners of those facing Parkinson’s shouldered $8,300,000,000 in lost earnings and productivity due to reduced work hours and early retirement in 2024; and
Whereas more research, education, and community support services are needed—
to find better treatments and a cure for Parkinson’s disease; and
to maintain the dignity of individuals living with Parkinson's disease: Now, therefore, be it
That the House of Representatives—
expresses support for the designation of Parkinson’s Awareness Month
;
supports the goals and ideals of Parkinson’s Awareness Month;
continues to support research to find better treatments and a cure for Parkinson’s disease;
recognizes the individuals living with Parkinson’s disease who participate in vital clinical trials to advance the knowledge of the disease; and
commends the dedication of organizations, volunteers, researchers, and millions of individuals across the United States working to improve the quality of life of people living with Parkinson’s disease and their families.